![Michael Forer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Forer
Director/Board Member at
GH RESEARCH PLC
Net worth: 1 M $ as of 31/05/2026
Profile
Michael Forer is the founder of Rosetta Capital Ltd., founded in 2001, holding the title of Partner.
Current jobs include Chairman at KDev Oncology AB, Vice Chairman at GH Research Plc since 2022, Director at ADC Products (UK) Ltd. since 2009, Director at ADC Therapeutics (UK) Ltd. since 2014, Director at GH Research Ireland Ltd., Member at The Law Society of Upper Canada, and Senior Partner at Badertscher Rechtsanwälte AG.
Former jobs include Vice Chairman at ADC Therapeutics SA from 2022 to 2023, Chairman at KDev Investments AB, Director at Rose Pharma A, Managing Director at Auven Therapeutics Management LLLP, Managing Director at Auven Therapeutics Holdings LP from 2008 to 2015, Executive Director at Spirogen SARL from 2008 to 2013, Investment Manager at Rothschild & Co. Asset Management US, Inc., and Principal at Norton Rose LLP.
Education includes a graduate degree from the University of British Columbia conferred in 1990 and an undergraduate degree from the University of Western Ontario conferred in 1986.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GH RESEARCH PLC 0.07% | 18/03/2026 | 45,509 ( 0.07% ) | 1 M $ | 31/05/2026 |
Michael Forer active positions
| Companies | Position | Start |
|---|---|---|
| GH RESEARCH PLC | Director/Board Member | 01/12/2020 |
Rosetta Capital Ltd.
 Rosetta Capital Ltd. Investment ManagersFinance Rosetta Capital invests in early and mid-stage growth companies in biotechnology-related sectors. The firm invest in acquisition financing and spin-off transactions. | Founder | 01/01/2001 |
GH Research Ireland Ltd.
 GH Research Ireland Ltd. Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage biopharmaceutical company which develops novel therapies for the management of mental diseases | Director/Board Member | - |
Badertscher Rechtsanwälte AG
 Badertscher Rechtsanwälte AG Miscellaneous Commercial ServicesCommercial Services Operates as law firm | President | - |
The Law Society of Upper Canada
 The Law Society of Upper Canada Miscellaneous Commercial ServicesCommercial Services Operates lawyer's association | Corporate Officer/Principal | - |
ADC Therapeutics (UK) Ltd.
 ADC Therapeutics (UK) Ltd. BiotechnologyHealth Technology Provides research and experimental development in biotechnology | Director/Board Member | 12/12/2014 |
ADC Products (UK) Ltd.
 ADC Products (UK) Ltd. Medical/Nursing ServicesHealth Services Develops therapeutic technologies for cancer and infectious diseases treatment | Director/Board Member | 28/09/2009 |
KDev Oncology AB
 KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services Offers research and development services in the field of oncology | Chairman | - |
Former positions of Michael Forer
| Companies | Position | End |
|---|---|---|
| ADC THERAPEUTICS SA | Chief Executive Officer | 22/06/2015 |
| ░░░░░ ░░░░░░░░░░░░ ░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░ ░░░ ░░░░░ ░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Michael Forer
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
89
1st degree connections
18
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 18 |
|---|---|
Rothschild & Co. Asset Management US, Inc.
 Rothschild & Co. Asset Management US, Inc. Investment ManagersFinance R&Co actively manages their portfolios with a goal of outperforming the indices, whatever the market conditions, and with a controlled level of risk. The firm’s investment strategy is based on three key principles that drive their investment decisions regarding allocation, sector and stock selection. Their three core investment principles are Conviction, Fundamentals and Convexity. | Finance |
Norton Rose LLP
 Norton Rose LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Western Ontario
 University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rosetta Capital Ltd.
Rosetta Capital Ltd. Investment ManagersFinance Rosetta Capital invests in early and mid-stage growth companies in biotechnology-related sectors. The firm invest in acquisition financing and spin-off transactions. | Finance |
Rose Pharma A/S
 Rose Pharma A/S Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products for treatment of pain in connection with irritable bowel syndrome | Health Technology |
The Law Society of Upper Canada
The Law Society of Upper Canada Miscellaneous Commercial ServicesCommercial Services Operates lawyer's association | Commercial Services |
Auven Therapeutics Management LLLP
 Auven Therapeutics Management LLLP Investment ManagersFinance Auven Therapeutics Management focuses on acquiring novel, life-saving and quality of life-enhancing products and accelerating the development of these products. They take ownership and control of the development of carefully selected clinical-stage therapeutic assets in order to build value around them to the point where they are attractive acquisition opportunities for established pharmaceutical and biotechnology companies. | Finance |
Auven Therapeutics Holdings LP
 Auven Therapeutics Holdings LP Investment ManagersFinance Acts as Private Equity Fund | Finance |
ADC Products (UK) Ltd.
ADC Products (UK) Ltd. Medical/Nursing ServicesHealth Services Develops therapeutic technologies for cancer and infectious diseases treatment | Health Services |
Badertscher Rechtsanwälte AG
Badertscher Rechtsanwälte AG Miscellaneous Commercial ServicesCommercial Services Operates as law firm | Commercial Services |
KDev Oncology AB
KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services Offers research and development services in the field of oncology | Commercial Services |
ADC Therapeutics SA
 ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
KDev Investments AB
 KDev Investments AB BiotechnologyHealth Technology Engages in research, sales, and development in the fields of medicine and owns and manages investments | Health Technology |
Spirogen SARL
 Spirogen SARL Miscellaneous Commercial ServicesCommercial Services Operates as an oncology-focused biotechnology company | Commercial Services |
ADC Therapeutics (UK) Ltd.
ADC Therapeutics (UK) Ltd. BiotechnologyHealth Technology Provides research and experimental development in biotechnology | Health Technology |
GH Research Ireland Ltd.
GH Research Ireland Ltd. Miscellaneous Commercial ServicesCommercial Services Operates clinical-stage biopharmaceutical company which develops novel therapies for the management of mental diseases | Commercial Services |
GH Research Plc
 GH Research Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel therapies for the management of psychiatric and neurological disorders | Health Technology |
- Stock Market
- Insiders
- Michael Forer
